Recent Updates
Recently added Catalysts
TMDX Negative Sentiment Score: 20/100

TransMedics Group, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – TMDX

Key Takeaway: TransMedics Group, Inc. is facing a class action lawsuit for securities law violations, with allegations spanning from fraudulent overbilling to unsafe business practices. The suit claims the company misled investors with materially false statements from February 28, 2023, to January 10, 2025. Shareholders are urged to register for participation in the legal proceedings, including the opportunity to become lead plaintiffs. The Gross Law Firm, which specializes in securing investor rights, is handling the case.

Market Sentiment Analysis

CONCERNS & RISKS

  • TransMedics allegedly engaged in fraudulent practices such as kickbacks and overbilling.
  • Unsafe practices were reported, with claims of undisclosed safety issues and lack of oversight.
  • The company is facing heightened scrutiny and regulatory risks due to its alleged misdeeds.
  • Statements made by the company regarding its operations and prospects were described as misleading and lacking a reasonable basis.

Full Press Release Details

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. (NASDAQ: TMDX).
Shareholders who purchased shares of TMDX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: February 28, 2023 to January 10, 2025
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue; (2) TransMedics engaged in unsafe practices and hid safety issues and generally lacked safety oversight; (3) the foregoing subjected TransMedics to heightened risk of scrutiny and regulatory risk; and (4) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
DEADLINE: April 15, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/transmedics-group-inc-loss-submission-form-2/?id=137110&from=3
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of TMDX during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 15, 2025. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
15 West 38th Street, 12th floor
Phone: (646) 453-8903

Tags

Frequently Asked Questions

What is the class period for TransMedics Group shareholders?

The class period is from February 28, 2023, to January 10, 2025.

What allegations are made against TransMedics Group?

Allegations include fraudulent practices, safety issues, and misleading statements.

When is the deadline to register for the class action?

The deadline to register is April 15, 2025.

Is there a cost to participate in this case?

No, there is no cost or obligation to participate in this case.

Last updated: Mar 20, 2025